Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Weigert

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Blood Advances|April 4, 2019
Impact of age on clinical risk scores in follicular lymphomaStefan Alig, Vindi Jurinovic, Alessandro Pastore, et al.
NPJ Precision Oncology|January 25, 2025
Adding checkpoint inhibitors to first-line chemotherapy for NUT carcinoma patientsSarah Haebe, Gesa Schuebbe, Philipp Jurmeister, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 2, 2018
Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study GroupVindi Jurinovic, Bernd Metzner, Michael Pfreundschuh, et al.
Blood|August 24, 2012
Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2Diederik van Bodegom, Jun Zhong, Nadja Kopp, et al.
Plos One|November 13, 2012
Next-generation cDNA screening for oncogene and resistance phenotypesNobuaki Shindoh, Akinori Yoda, Yuka Yoda, et al.
Haematologica|April 23, 2026
Circulating tumor DNA at baseline as a prognostic marker in untreated follicular lymphomaCorinna Lutterbeck, Derrick Kaufman, Christopher R Bolen, et al.
Infection|October 4, 2022
Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopeniaMichael Ruzicka, Sonja Wurm, Lars Lindner, et al.
Oncotarget|June 11, 2016
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclonesThomas Melchardt, Clemens Hufnagl, David M Weinstock, et al.
Haematologica|January 5, 2019
Convergence of risk prediction models in follicular lymphomaAnjali Silva, Sleiman Bassim, Clémentine Sarkozy, et al.
Blood|January 29, 2021
Treatment dependence of prognostic gene expression signatures in de novo follicular lymphomaChristopher R Bolen, Federico Mattiello, Michael Herold, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Blood Advances|April 4, 2019
Impact of age on clinical risk scores in follicular lymphomaStefan Alig, Vindi Jurinovic, Alessandro Pastore, et al.
NPJ Precision Oncology|January 25, 2025
Adding checkpoint inhibitors to first-line chemotherapy for NUT carcinoma patientsSarah Haebe, Gesa Schuebbe, Philipp Jurmeister, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 2, 2018
Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study GroupVindi Jurinovic, Bernd Metzner, Michael Pfreundschuh, et al.
Blood|August 24, 2012
Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2Diederik van Bodegom, Jun Zhong, Nadja Kopp, et al.
Plos One|November 13, 2012
Next-generation cDNA screening for oncogene and resistance phenotypesNobuaki Shindoh, Akinori Yoda, Yuka Yoda, et al.
Haematologica|April 23, 2026
Circulating tumor DNA at baseline as a prognostic marker in untreated follicular lymphomaCorinna Lutterbeck, Derrick Kaufman, Christopher R Bolen, et al.
Infection|October 4, 2022
Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopeniaMichael Ruzicka, Sonja Wurm, Lars Lindner, et al.
Oncotarget|June 11, 2016
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclonesThomas Melchardt, Clemens Hufnagl, David M Weinstock, et al.
Haematologica|January 5, 2019
Convergence of risk prediction models in follicular lymphomaAnjali Silva, Sleiman Bassim, Clémentine Sarkozy, et al.
Blood|January 29, 2021
Treatment dependence of prognostic gene expression signatures in de novo follicular lymphomaChristopher R Bolen, Federico Mattiello, Michael Herold, et al.
Pageof 8